Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study
Objective Fatigue is among the most distressing symptoms across the breast cancer continuum. However, little is known about the factors contributing to long‐term persisting fatigue. Therefore, we explored determinants of long‐term physical, affective, and cognitive fatigue in a prospective cohort of...
Saved in:
Published in | Psycho-oncology (Chichester, England) Vol. 24; no. 1; pp. 40 - 46 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.01.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1057-9249 1099-1611 1099-1611 |
DOI | 10.1002/pon.3581 |
Cover
Summary: | Objective
Fatigue is among the most distressing symptoms across the breast cancer continuum. However, little is known about the factors contributing to long‐term persisting fatigue. Therefore, we explored determinants of long‐term physical, affective, and cognitive fatigue in a prospective cohort of breast cancer patients.
Methods
Breast cancer patients recruited in a population‐based case–control study (MARIE study) provided comprehensive data on sociodemographics, lifestyle, and preexisting medical conditions. At follow‐up (median 6.3 years post‐diagnosis, MARIEplus), disease‐free cancer survivors (N = 1928) reported current fatigue using a validated multidimensional questionnaire. Additionally, survivors retrospectively rated their fatigue levels before diagnosis, during the treatment phase, and 1 year post‐surgery. Linear regression analyses were performed.
Results
As major determinants of long‐term physical, affective, and cognitive fatigue, multiple regression analyses revealed preexisting psychological or depressive disorders, migraine, analgesic use, peripheral arterial obstructive disease (PAOD), and arthritis. A physically inactive lifestyle and obesity were associated with persisting physical fatigue. Aromatase inhibitors were also associated with long‐term fatigue, especially cognitive fatigue. Chemotherapy and, to a lower extent, radiotherapy were major contributors to the development of fatigue during the treatment phase, yet were not associated with long‐term fatigue.
Conclusions
Although the development of fatigue in breast cancer patients seems largely impacted by cancer therapy, for the long‐term persistence of fatigue, preexisting medical or psychological conditions related to depression or pain and lifestyle factors appear to be more relevant. Physicians, psycho‐oncologists, and researchers may need to distinguish between acute fatigue during therapy and long‐term persisting fatigue with regard to its pathophysiology and treatment. Copyright © 2014 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | istex:4C8AE69EFCFC843F00ED076A0A18B830DC883B5E ArticleID:PON3581 Deutsche Krebshilfe e. V. - No. 70-2892-BR I; No. 108253/108419 Hamburg Cancer Society, the German Cancer Research Centre, and the German Federal Ministry for Education and Research - No. 01KH0402 ark:/67375/WNG-RKXQ597M-5 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
ISSN: | 1057-9249 1099-1611 1099-1611 |
DOI: | 10.1002/pon.3581 |